RUA Life Sciences PLC

AOHA

Company Profile

  • Business description

    RUA Life Sciences PLC is engaged in contract design and manufacture of medical devices and exploiting the value of its IP and know-how, and developing of cardiovascular devices. Its segments include Biomaterials includes Licensor of Elast-Eon polymers to the medical device industry; Medical Devices and Components engages End-to-end contract developer, manufacturer, and seller of medical devices and implantable fabric specialist; Vascular engages in the development and commercialization of the group’s Elast-Eon sealed Vascular Graft products; and Structural Heart engages in the development of the group’s Elast-Eon composite heart valve material AurTex. Geographically it operates in Europe, North America, Middle East , Asia Pacific, and Africa.

  • Contact

    2 Drummond Crescent
    Ayrshire
    Scotland
    IrvineKA11 5AN
    GBR

    T: +44 1294317073

    E: [email protected]

    https://www.rualifesciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2026

    Employees

    40

Stocks News & Analysis

stocks

Investors overly concerned about AI impact on ASX share

Shares screen as undervalued after prolonged decline.
stocks

After earnings, is Palantir stock a buy, a sell, or fairly valued?

With higher-than-expected revenue expectations and a raised fair value estimate, here’s what we think of Palantir stock.
stocks

Rio Tinto and Glencore go their separate ways

Our view after merger talks end.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,139.9034.50-0.38%
CAC 408,323.2849.440.60%
DAX 4025,014.87293.411.19%
Dow JONES (US)50,135.8720.200.04%
FTSE 10010,386.2316.480.16%
HKSE27,140.51113.350.42%
NASDAQ23,238.67207.460.90%
Nikkei 22557,660.071,296.132.30%
NZX 50 Index13,513.6867.310.50%
S&P 5006,964.8232.520.47%
S&P/ASX 2008,867.4044.20-0.50%
SSE Composite Index4,129.356.260.15%

Market Movers